Stock PRDS PARDES BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders Pardes Biosciences, Inc.

Equities

PRDS

US69945Q1058

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pardes Biosciences, Inc. Announces Termination of Brian P. Kearney as Chief Development Office, Effective May 15, 2023
CI
Pardes Biosciences, Inc. Announces Executive Changes, Effective November 30, 2022
CI
Pardes Biosciences, Inc. Appoints Laurie Smaldone Alsup, M.D. and John C. Pottage, Jr., M.D. to Board of Directors
CI
Pardes Biosciences Names Thomas Wiggans Chief Executive, Chairman
MT
Pardes Biosciences Appoints Thomas G. Wiggans to CEO
CI
Pardes Biosciences, Inc. Announces Board Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PRDS Stock
  4. News Pardes Biosciences, Inc.
  5. Insiders